tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Karanam BV et al. Disposition of L-732,531, a potent immunosuppressant, in rats and baboons. 1998 Drug Metab. Dispos. pmid:9763399
Billaud EM et al. Evidence for a pharmacokinetic interaction between itraconazole and tacrolimus in organ transplant patients. 1998 Br J Clin Pharmacol pmid:9764970
Wang JD et al. Lymphotactin: a key regulator of lymphocyte trafficking during acute graft rejection. 1998 Immunology pmid:9767457
Hauser IA et al. Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells. 1998 Kidney Int. pmid:9767529
Lamb ML and Jorgensen WL Investigations of neurotrophic inhibitors of FK506 binding protein via Monte Carlo simulations. 1998 J. Med. Chem. pmid:9767630
Bennett WM The nephrotoxicity of new and old immunosuppressive drugs. 1998 Ren Fail pmid:9768435
Luo Z et al. Calcineurin inhibitors and cardiac hypertrophy. 1998 Nat. Med. pmid:9771723
Gómez J et al. The Bcl-2 gene is differentially regulated by IL-2 and IL-4: role of the transcription factor NF-AT. 1998 Oncogene pmid:9771966
Fellermann K et al. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). 1998 Am. J. Gastroenterol. pmid:9772045
Chelmicka-Schorr E et al. Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats. 1998 J. Autoimmun. pmid:9776710
Weichert G and Sauder DN Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangrenosum. 1998 J. Am. Acad. Dermatol. pmid:9777778
Motamedi H and Shafiee A The biosynthetic gene cluster for the macrolactone ring of the immunosuppressant FK506. 1998 Eur. J. Biochem. pmid:9780228
Maestri M et al. [Treatment of the nephrotoxicity of immunosuppressive drugs with insulin-like growth factor-I]. 1998 Minerva Chir pmid:9780630
Nishida T et al. [FK506 for the prophylaxis of graft-versus-host-disease after bone marrow transplantation from HLA-genotypically mismatched unrelated donor]. 1998 Rinsho Ketsueki pmid:9785975
Rayes N et al. Pregnancies following liver transplantation--how safe are they? A report of 19 cases under cyclosporine A and tacrolimus. 1998 Clin Transplant pmid:9787947
Peddi VR et al. Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation. 1998 Clin Transplant pmid:9787948
Wu A et al. Outcome of 22 successful pregnancies after liver transplantation. 1998 Clin Transplant pmid:9787957
Heering P et al. Distal tubular acidosis induced by FK506. 1998 Clin Transplant pmid:9787958
Masugi T and Otsuka K [Immunosuppressive drugs and calcineurin]. 1998 Tanpakushitsu Kakusan Koso pmid:9788176
Bajaj-Elliott M et al. Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. 1998 J. Clin. Invest. pmid:9788959